Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)Application
Figure 2:Western blot analysis using KRT18 mAb against human KRT18 (AA: 1-150) recombinant protein. (Expected MW is 42.1 kDa)Application
Figure 3:Western blot analysis using KRT18 mAb against HEK293 (1) and KRT18 (AA: 1-150)-hIgGFc transfected HEK293 (2) cell lysate.Application
Figure 4:Western blot analysis using KRT18 mouse mAb against SK-BR-3 (1), HepG2 (2), T47D (3), MCF-7 (4), Hela (5), A431 (6), and HCT116 (7) cell lysate.Application
Figure 5:Immunofluorescence analysis of Hela cells using KRT18 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)Application
Figure 6:Flow cytometric analysis of Hela cells using KRT18 mouse mAb (green) and negative control (red).Application
Figure 7:Immunohistochemical analysis of paraffin-embedded lung cancer tissues using KRT18 mouse mAb with DAB staining.Application
Figure 8:Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using KRT18 mouse mAb with DAB staining.| Product Name | KRT18 |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | K18; CK-18; CYK18 |
| Immunogen | Purified recombinant fragment of human KRT18 (AA: 1-150) expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBIHCICCFCMICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC:1:100~1:200 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | K18 CK-18 CYK18 |
|---|---|
| Molecular Weight(MW) | 48kDa |
| Entrez Gene | 3875 |
|---|
Application
Figure 1:Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)
Application
Figure 2:Western blot analysis using KRT18 mAb against human KRT18 (AA: 1-150) recombinant protein. (Expected MW is 42.1 kDa)
Application
Figure 3:Western blot analysis using KRT18 mAb against HEK293 (1) and KRT18 (AA: 1-150)-hIgGFc transfected HEK293 (2) cell lysate.
Application
Figure 4:Western blot analysis using KRT18 mouse mAb against SK-BR-3 (1), HepG2 (2), T47D (3), MCF-7 (4), Hela (5), A431 (6), and HCT116 (7) cell lysate.
Application
Figure 5:Immunofluorescence analysis of Hela cells using KRT18 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Secondary antibody from Fisher (Cat#: 35503)
Application
Figure 6:Flow cytometric analysis of Hela cells using KRT18 mouse mAb (green) and negative control (red).
Application
Figure 7:Immunohistochemical analysis of paraffin-embedded lung cancer tissues using KRT18 mouse mAb with DAB staining.
Application
Figure 8:Immunohistochemical analysis of paraffin-embedded rectum cancer tissues using KRT18 mouse mAb with DAB staining.| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC:1:100~1:200 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Purified antibody in PBS with 0.05% sodium azide |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
